DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Systemic lupus erythematosus	R-HSA-977105	map05322	(-)-atenolol	237	drug-path
MAPK signaling pathway	R-HSA-9652817	map04010	(-)-atenolol	237	drug-path
Basal cell carcinoma	R-HSA-5626181	map05217	(-)-atenolol	237	drug-path
Renal cell carcinoma	R-HSA-9794523	map05211	(-)-atenolol	237	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	betamethasone	9782	drug-path
Complement and coagulation cascades	R-HSA-114591	map04610	betamethasone	9782	drug-path
Olfactory transduction	R-HSA-9751605	map04740	betamethasone	9782	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	dexibuprofen	39912	drug-path
RNA polymerase	R-HSA-73864	map03020	dexibuprofen	39912	drug-path
Graft-versus-host disease	R-HSA-1643685	map05332	promethazine	4927	drug-path
Natural killer cell mediated cytotoxicity	R-HSA-5218921	map04650	promethazine	4927	drug-path
Pathways in cancer	R-HSA-9824443	map05200	promethazine	4927	drug-path
Autoimmune thyroid disease	R-HSA-1643685	map05320	promethazine	4927	drug-path
Olfactory transduction	R-HSA-9751605	map04740	promethazine	4927	drug-path
Focal adhesion	R-HSA-354113	map04510	promethazine	4927	drug-path
Acute myeloid leukemia	R-HSA-9680350	map05221	promethazine	4927	drug-path
ECM-receptor interaction	R-HSA-373711	map04512	promethazine	4927	drug-path
Allograft rejection	R-HSA-9679028	map05330	promethazine	4927	drug-path
Type I diabetes mellitus	R-HSA-5683209	map04940	promethazine	4927	drug-path
Chronic myeloid leukemia	R-HSA-9680350	map05220	promethazine	4927	drug-path